108 related articles for article (PubMed ID: 2538128)
1. The antiviral activity of 9-beta-D-arabinofuranosyladenine is enhanced by the 2',3'-dideoxyriboside, the 2',3'-didehydro-2',3'-dideoxyriboside and the 3'-azido-2',3'-dideoxyriboside of 2,6-diaminopurine.
Balzarini J; De Clercq E
Biochem Biophys Res Commun; 1989 Feb; 159(1):61-7. PubMed ID: 2538128
[TBL] [Abstract][Full Text] [Related]
2. The 2',3'-dideoxyriboside of 2,6-diaminopurine and its 2',3'-didehydro derivative inhibit the deamination of 2',3'-dideoxyadenosine, an inhibitor of human immunodeficiency virus (HIV) replication.
Balzarini J; Robins MJ; Zou RM; Herdewijn P; De Clercq E
Biochem Biophys Res Commun; 1987 May; 145(1):277-83. PubMed ID: 3496090
[TBL] [Abstract][Full Text] [Related]
3. Potent and selective activity of 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside, 3'-fluoro-2,6-diaminopurine-2',3'-dideoxyriboside, and 3'-fluoro-2',3'-dideoxyguanosine against human immunodeficiency virus.
Balzarini J; Baba M; Pauwels R; Herdewijn P; Wood SG; Robins MJ; de Clercq E
Mol Pharmacol; 1988 Mar; 33(3):243-9. PubMed ID: 3258404
[TBL] [Abstract][Full Text] [Related]
4. The 2',3'-dideoxyriboside of 2,6-diaminopurine selectively inhibits human immunodeficiency virus (HIV) replication in vitro.
Balzarini J; Pauwels R; Baba M; Robins MJ; Zou RM; Herdewijn P; De Clercq E
Biochem Biophys Res Commun; 1987 May; 145(1):269-76. PubMed ID: 3496089
[TBL] [Abstract][Full Text] [Related]
5. Potentiating effect of ribavirin on the anti-retrovirus activity of 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside in vitro and in vivo.
Balzarini J; Herdewijn P; De Clercq E
Antiviral Res; 1989; 11(4):161-71. PubMed ID: 2545163
[TBL] [Abstract][Full Text] [Related]
6. Investigations on the anti-HIV activity of 2',3'-dideoxyadenosine analogues with modifications in either the pentose or purine moiety. Potent and selective anti-HIV activity of 2,6-diaminopurine 2',3'-dideoxyriboside.
Pauwels R; Baba M; Balzarini J; Herdewijn P; Desmyter J; Robins MJ; Zou RM; Madej D; De Clercq E
Biochem Pharmacol; 1988 Apr; 37(7):1317-25. PubMed ID: 3258516
[TBL] [Abstract][Full Text] [Related]
7. Study on the apparent resistant strains of herpes simplex virus type 1 against 9-beta-D-arabinofuranosyladenine.
Yoshida T; Suzutani T; Azuma M
Tohoku J Exp Med; 1988 Nov; 156(3):279-90. PubMed ID: 2855280
[TBL] [Abstract][Full Text] [Related]
8. Differential sensitivity of herpes simplex virus types 1 and 2 to human interferon: antiviral effects of interferon plus 9-beta-D-arabinofuranosyladenine.
Lerner AM; Bailey EJ
J Infect Dis; 1976 Oct; 134(4):400-4. PubMed ID: 185303
[TBL] [Abstract][Full Text] [Related]
9. Nucleic acid related compounds. 57. Synthesis, x-ray crystal structure, lipophilic partition properties, and antiretroviral activities of anomeric 3'-azido-2',3'-dideoxy-2,6-diaminopurine ribosides.
Robins MJ; Wood SG; Dalley NK; Herdewijn P; Balzarini J; De Clercq E
J Med Chem; 1989 Aug; 32(8):1763-8. PubMed ID: 2754702
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the herpes simplex virus DNA polymerase gene can confer resistance to 9-beta-D-arabinofuranosyladenine.
Coen DM; Furman PA; Gelep PT; Schaffer PA
J Virol; 1982 Mar; 41(3):909-18. PubMed ID: 6284981
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of duck hepatitis B virus replication by purine 2',3'-dideoxynucleosides.
Suzuki S; Lee B; Luo W; Tovell D; Robins MJ; Tyrrell DL
Biochem Biophys Res Commun; 1988 Nov; 156(3):1144-51. PubMed ID: 3190693
[TBL] [Abstract][Full Text] [Related]
12. Intracellular metabolism of 2',3'-dideoxynucleosides in duck hepatocyte primary cultures.
Kitos TE; Tyrrell DL
Biochem Pharmacol; 1995 May; 49(9):1291-302. PubMed ID: 7763311
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo comparison of the abilities of purine and pyrimidine 2',3'-dideoxynucleosides to inhibit duck hepadnavirus.
Lee B; Luo WX; Suzuki S; Robins MJ; Tyrrell DL
Antimicrob Agents Chemother; 1989 Mar; 33(3):336-9. PubMed ID: 2729928
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of N6- or 8-substituted 9-(beta-D-arabinofuranosyl)-adenines and their antiviral activities against herpes simplex and vaccinia viruses.
Kaneko M; Kimura M; Nishimura T; Shimizu B
Chem Pharm Bull (Tokyo); 1977 Oct; 25(10):2482-9. PubMed ID: 201386
[No Abstract] [Full Text] [Related]
15. Herpes simplex virus mutants resistant to arabinosyladenine in the presence of deoxycoformycin.
Fleming HE; Coen DM
Antimicrob Agents Chemother; 1984 Sep; 26(3):382-7. PubMed ID: 6095755
[TBL] [Abstract][Full Text] [Related]
16. Antiviral activity of an adenosine deaminase inhibitor: decreased replication of herpes simplex virus.
Williams BB; Lerner AM
J Infect Dis; 1975 Jun; 131(6):673-7. PubMed ID: 166117
[TBL] [Abstract][Full Text] [Related]
17. Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice.
Shannon WM; Arnett G; Schabel FM; North TW; Cohen SS
Antimicrob Agents Chemother; 1980 Oct; 18(4):598-603. PubMed ID: 6255863
[TBL] [Abstract][Full Text] [Related]
18. Anti-herpes activity of the adenine arabinoside analog, 2'-azido-2'-deoxy-beta-D-arabinofuranosyladenine.
Cermak-Mörth CM; Christian R; Unger FM
Biochem Pharmacol; 1979 Jul; 28(13):2105-8. PubMed ID: 224885
[No Abstract] [Full Text] [Related]
19. Differential and selective inhibition of cellular and herpes simplex virus DNA synthesis by arabinofuranosyladenine.
Falke D; Ronge K; Arendes J; Müller WE
Biochim Biophys Acta; 1979 Jun; 563(1):36-45. PubMed ID: 227462
[TBL] [Abstract][Full Text] [Related]
20. Determination of plaque inhibitory activity of adenine arabinoside (9-beta-D-arabinofuranosyladenine) for herpesviruses using an adenosine deaminase inhibitor.
Bryson Y; Connor JD; Sweetman L; Carey S; Stuckey MA; Buchanan R
Antimicrob Agents Chemother; 1974 Jul; 6(1):98-101. PubMed ID: 15828177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
